Zhittya Genesis Medicine Inc.

Heart disease, stroke, diabetic foot ulcers, Alzheimers disease, Parkinsons disease, and more: Can these disorders be treated or even cured with angiogenesis? Zhittya Genesis Medicine (ZGM) is a biopharmaceutical company, developing for FDA approval, a biological drug which triggers angiogenesis and neurogenesis. Does ZGM have possible treatment for diseases that kill over 50% of the people in the world.

Company Schedule

Tuesday, September 29, 2020 - 4:00 pm to 4:30 pm EDT A Biotech Company Developing a Major Medical Breakthrough: Learn About Opportunities for Pre-IPO Investments for Qualified Investors by Jack Jacobs - President and Chief Scientific Officer, Zhittya Genesis Medicine, Inc. Focus: BIOTECH

Zhittya Genesis Medicine is a biotech company advancing, through FDA-authorized clinical trials, a biological drug that triggers angiogenesis (growth of new blood vessels) in damaged or ischemic tissues. This breakthrough medical treatment has the potential to reverse diseases which cause suffering and death for over 50% of all adults worldwide, including heart disease, strokes, diabetic foot ulcers, Parkinsons disease, Alzheimers disease, and multiple sclerosis. Zhittya believes its drug could extend human life an additional 20 to 30 years with good quality health.


How did you hear about the Event?*

By clicking the check box above, you agree and provide express consent to receive email updates and special offers from MoneyShow, and separately from its partners, speakers, advertisers and other companies, designed for the investing and trading community. You also agree to MoneyShow's Privacy Policy and website Terms of Service. You further agree and provide express consent to your contact information/data being shared with those presenter(s) and other companies who may pay to support your opportunity to view, hear, or download this event. A list of those presenters and companies can be found by clicking this link. To withdraw your consent from other third parties you should do so directly with those parties through their own opt-out processes.

For questions please contact our Client Relations Team at 800-970-4355 or 941-955-0323.

Social Updates

Follow us on social media to stay in the loop as more great speakers are added to the schedule!